Pharmanutra S.p.A. (PHN.MI)

EUR 54.8

(1.86%)

EBITDA Summary of Pharmanutra S.p.A.

Pharmanutra S.p.A.'s latest annual EBITDA in 2023 was 26.53 Million EUR , up 0.94% from previous year.
Pharmanutra S.p.A.'s latest quarterly EBITDA in 2024 Q2 was 11.25 Million EUR , up 147.39% from previous quarter.
Pharmanutra S.p.A. reported an annual EBITDA of 24.61 Million EUR in 2022, up 21.79% from previous year.
Pharmanutra S.p.A. reported an annual EBITDA of 19.3 Million EUR in 2021, up 29.04% from previous year.
Pharmanutra S.p.A. reported a quarterly EBITDA of 11.25 Million EUR for 2024 Q2, up 147.39% from previous quarter.
Pharmanutra S.p.A. reported a quarterly EBITDA of 4.21 Million EUR for 2023 Q4, down -21.12% from previous quarter.

Annual EBITDA Chart of Pharmanutra S.p.A. (2023 - 2015)

Historical Annual EBITDA of Pharmanutra S.p.A. (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	26.53 Million EUR	0.94%
2022	24.61 Million EUR	21.79%
2021	19.3 Million EUR	29.04%
2020	15.1 Million EUR	18.27%
2019	12.92 Million EUR	7.13%
2018	12.36 Million EUR	31.31%
2017	9.38 Million EUR	30.21%
2016	7.29 Million EUR	52.79%
2015	4.73 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	4.95 Million EUR	-2.1%
2024 Q2	11.25 Million EUR	147.39%
2023 Q4	4.21 Million EUR	-21.12%
2023 FY	- EUR	0.94%
2023 Q1	6.87 Million EUR	29.05%
2023 Q2	7.56 Million EUR	10.08%
2023 Q3	5.34 Million EUR	-29.35%
2022 FY	- EUR	21.79%
2022 Q4	5.32 Million EUR	-25.18%
2022 Q3	7.11 Million EUR	-0.46%
2022 Q2	7.15 Million EUR	34.6%
2022 Q1	5.31 Million EUR	33.87%
2021 Q4	3.96 Million EUR	-25.46%
2021 Q3	5.32 Million EUR	-16.7%
2021 FY	- EUR	29.04%
2021 Q1	3.83 Million EUR	10.28%
2021 Q2	6.39 Million EUR	66.8%
2020 Q4	3.47 Million EUR	38.63%
2020 FY	- EUR	18.27%
2020 Q1	2.99 Million EUR	-27.96%
2020 Q2	6.65 Million EUR	122.47%
2020 Q3	2.5 Million EUR	-62.34%
2019 Q3	2.8 Million EUR	-12.54%
2019 Q4	4.15 Million EUR	48.23%
2019 FY	- EUR	7.13%
2019 Q1	3.2 Million EUR	1.99%
2019 Q2	3.2 Million EUR	0.0%
2018 Q1	2.72 Million EUR	13.38%
2018 FY	- EUR	31.31%
2018 Q4	3.13 Million EUR	0.0%
2018 Q3	3.13 Million EUR	15.25%
2018 Q2	2.72 Million EUR	0.0%
2017 FY	- EUR	30.21%
2017 Q1	2.28 Million EUR	36.84%
2017 Q2	2.28 Million EUR	0.0%
2017 Q3	2.4 Million EUR	5.02%
2017 Q4	2.4 Million EUR	0.0%
2016 Q1	1.78 Million EUR	0.0%
2016 Q2	1.78 Million EUR	-0.0%
2016 Q3	1.78 Million EUR	0.01%
2016 Q4	1.67 Million EUR	-6.18%
2016 FY	- EUR	52.79%
2015 FY	- EUR	0.0%

Peer EBITDA Comparison of Pharmanutra S.p.A.

Name	EBITDA	EBITDA Difference